Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The high prevalence of dermatophytosis in animals is usually associated with extra expenditure on prevention, diagnosis, and long‐term treatment. Humans are usually infected from animals, also from asymptomatic carriers, through direct contact or indirectly via fungus‐bearing hair, scales, and fomites. Despite the medical importance of <i>Trichophyton verrucosum</i> infections, there are limited <i>in vitro</i> data on the fungal susceptibility to antifungal drugs, including new‐generation triazoles, imidazoles, and allyloamines. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>The aim of the current study was to evaluate comprehensively the <i>in vitro</i> activity of 11 antifungal drugs against a large collection of <i>T. verrucosum</i> isolates obtained in Poland, Latvia, Lithuania, and Slovakia from humans and animals using a microdilution assay. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p><i>In vitro</i> susceptibility testing of 11 antifungal drugs was performed according to the Clinical and Laboratory Standards Institute (CLSI) document M38. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The MICs of clotrimazole, ciclopirox, enilconazole, miconazole, naftifine, and terbinafine against all <i>T. verrucosum</i> isolates were below 1 μg/ml, whereas those of fluconazole, griseofulvin, itraconazole, ketoconazole, and voriconazole were above 1 μg/ml. Ciclopirox was demonstrated to have superior activity against all strains in comparison with the other drugs, whereas fluconazole exerted the weakest <i>in vitro</i> effect and exhibited the highest MIC values. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study has shown that drugs of different chemical origin have satisfactory antifungal activity and can be promising candidates for the treatment of <i>T. verrucosum</i> dermatophytosis. Moreover, no significant disparity in drug sensitivity between isolates obtained from different hosts and geographical regions have been demonstrated. </p></section>

Identification and in Vitro Antifungal Susceptibility of Medically Important Trichosporon Species

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

Microbiological Characteristics of Medically Important Trichosporon Species

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.

Biological characteristics of Trichosporon veenhuisii

Identification of clinical common Trichosporon spp.

Analysis of antifungal susceptibility in vitro and fungi distribution in clinics

In vitro activities of nine antifungal agents against rare pathogenic fungi.

Susceptibility Test by Sodium Nitrite Combined with Antifungal Agents Against Trichophyton Rubrum in Vitro

Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin

Clinico-mycological study of onychomycosis and in vitro antifungal susceptibility of Trichophyton rubrum

Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum

Susceptibility Test by Berberine Hydrochloride Combined with Antifungal Agents Against Trichophyton Rubrum in Vitro

Antifungal susceptibility test for pathogenic Fusarium spp in vitro

In Vitro Combined Activity of Amphotericin B, Caspofungin and Voriconazole Against Clinical Isolates of Trichosporon Asahii

Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study

In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller–Hinton Agar Plates

Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates

Antifungal susceptibilities of 44 isolates of Trichophyton mentagrophytes isolates evaluated with CLSI M38-A2 scheme

Susceptibility Analysis of 60 Strains of Yeast-Like Fungi